FIND, CSIR-IGIB to strengthen genomic surveillance of SARS-CoV-2 in India

December 06, 2021 | Monday | News

The partnership will optimise and scale the capacity needed to identify SARS-CoV-2 variants of concern (VOC) and variants of interest (VOI)

Image Credit: Shutterstock

Image Credit: Shutterstock

FIND, the global alliance for diagnostics, has partnered with CSIR-IGIB (Institute of Genomics and Integrated Biology), New Delhi to aid India’s fight against COVID-19 by boosting sequencing capacity across the country.

 

The partnership aims to decentralise genomic surveillance of SARS-CoV-2, down to the district level by setting up MicroLabs that enable sequencing, analysis and interpretation of sequencing data with minimal turnaround time and infrastructure limited settings. 

 

As a co-lead of the Diagnostics Pillar of the Access to COVID-19 Tools (ACT) Accelerator, FIND is supporting India’s efforts towards the establishment of a robust genomic surveillance system. 

 

The partnership will provide strategic guidance to incorporate next-generation sequencing into broader national disease surveillance frameworks and inform data analyses, management and sharing based on global data policies and guidelines. It will provide a platform for knowledge-sharing and lessons learnt to inform national capacity-building efforts and policy guidance.

 

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy